Cited by 1,011Inflammatory mediators and NSAID effectsReceptor Mechanisms and SignalingEicosanoids and Hypertension Pharmacology

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Prostanoid Receptors: Subtypes and Signaling

Breyer, Richard M, Bagdassarian, Carey K, Myers, Scott A, Breyer, Matthew D·2001·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.41.1.661

Open this paper in CoChat — free account

Abstract

Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE 2, PGF 2α, PGI 2, TxA 2, and PGD 2. These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP 1, EP 3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.41.1.661

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,417
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,747
G Protein-coupled Receptors
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Tuder, R. M., Cool, C. D., Geraci, M. W., Wang, J., Abman, S. H., Wright, L. A., Badesch, D. B., & Voelkel, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 679
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677

Show all 152 references

Research works printed but not linked: 18

Coleman RA, 1994, Pharmacol. Rev., 46, 205
Leach AR. 1996.Molecular Modelling. Essex, England: Longman Ltd.pp. 25–90
Kolakowski L, 1994, Mol. Pharmacol. Recept. Channels, 2, 1
Morinelli TA, 1989, J. Pharmacol. Exp. Ther., 251, 557
Kinsella BT, 1997, J. Pharmacol. Exp. Ther., 281, 957
Funk CD, 1993, Mol. Pharmacol., 44, 934
Sakamoto K, 1994, J. Biol. Chem., 5, 3381
Fujino H, 2000, Mol. Pharmacol., 57, 353
Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. 1990.Prostanoids and their receptors.InComprehensive Medicinal Chemistry, ed. JC Emmet, pp. 643–714. Oxford, UK: Pergamon
Abramovitz M, 1995, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 499
Regan JW, 1994, Mol. Pharmacol., 46, 213
Guan Y, 1996, J. Am. Soc. Nephrol, 7, 1646
Nishigaki N, 1996, Mol. Pharmacol., 50, 1031
Perkins W, 1991, J. Pharmacol. Exp. Ther., 259, 1004
10.1042/0264-6021:3400365 · DOI
Audoly L, 1999, J. Pharmacol. Exp. Ther., 289, 140
Edwards RM, 1985, Am. J. Physiol., 248, F779
Kotani M, 1995, Mol. Pharmacol., 48, 869

Sorted by citations

Items 301–400 of 1,000

A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure
Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 51
Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing:In vivoandin vitroevidence
Graham, S. M., Gamie, Z., Polyzois, I., Narvani, A. A., Tzafetta, K., Tsiridis, E., Heliotis, M., Mantalaris, A., & Tsiridis, E. E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902893051 · Cited by 51
A Positive Feedback Loop that Regulates Cyclooxygenase-2 Expression and Prostaglandin F2α Synthesis via the F-Series-Prostanoid Receptor and Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway
Jabbour, H. N., Sales, K. J., Boddy, S. C., Anderson, R. A., & Williams, A. R. W. (2005) · Endocrinology · doi:10.1210/en.2005-0804 · Cited by 51
Isoprostanes and asthma
Voynow, J. A., & Kummarapurugu, A. B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.04.016 · Cited by 50
Cyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the Pathophysiological Mechanisms in the Rat Model of Depression
Chen, Q., Luo, Y., Kuang, S., Yang, Y., Tian, X., Ma, J., Mai, S., Xue, L., & Yang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00609-7 · Cited by 49
Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived Macrophages
Xiao, L., Ornatowska, M., Zhao, G., Cao, H., Yu, R., Deng, J., Li, Y., Zhao, Q., Sadikot, R. T., & Christman, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050244 · Cited by 49
Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention
Parida, S., & Mandal, M. (2014) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000023 · Cited by 48
Inducible Cyclooxygenase Released Prostaglandin E2 Modulates the Severity of Infection Caused by Streptococcus pyogenes
Goldmann, O., Hertzén, E., Hecht, A., Schmidt, H., Lehne, S., Norrby‐Teglund, A., & Medina, E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000838 · Cited by 48
Hypoxia upregulates PGI-synthase and increases PGI2 release in human vascular cells exposed to inflammatory stimuli
Camacho, M., Rodrı́guez, C., Guadall, A., Alcolea, S., Orriols, M., Escudero, J.-R., Martínez‐González, J., & Vila, L. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011007 · Cited by 48
Crosstalk between Prostaglandin E2 and Leukotriene B4 Regulates Phagocytosis in Alveolar Macrophages via Combinatorial Effects on Cyclic AMP
Lee, S. P., Serezani, C. H., de Medeiros, A. I., Ballinger, M. N., & Peters-Golden, M. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.530 · Cited by 48
Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines
Panzer, U., & Uguccioni, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425226 · Cited by 48
Eicosanoids and the Vascular Endothelium
Egan, K. M., & FitzGerald, G. A. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_6 · Cited by 52
Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation
Yuhki, K., Kojima, F., Yamada, T., Fujino, T., Hara, A., Takayama, K., Maruyama, T., Yoshida, A., Narumiya, S., Kuriyama, S., et al. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0043 · Cited by 47
E-Prostanoid 3 Receptor Deletion Improves Pulmonary Host Defense and Protects Mice from Death in Severe Streptococcus pneumoniae Infection
Aronoff, D. M., Lewis, C. A., Serezani, C. H., Eaton, K. A., Goel, D., Phipps, J. C., Peters-Golden, M. L., & Mancuso, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900129 · Cited by 47
Regulation of Microvascular Thromboembolism In Vivo
Egbrink, M. G. A. O., van Gestel, M. A., Broeders, M. A. W., Tangelder, G. J., Heemskerk, J. W. M., Reneman, R. S., & Slaaf, D. W. (2005) · Microcirculation · doi:10.1080/10739680590925628 · Cited by 47
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells
Baratelli, F. E., Krysan, K., Heuzé‐Vourc'h, N., Zhu, L. X., Escuadro, B., Sharma, S. P., Reckamp, K. L., Dohadwala, M., & Dubinett, S. M. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1004569 · Cited by 47
Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor
Clarke, D. L., Belvisi, M. G., Smith, S. J., Hardaker, E. L., Yacoub, M. H., Meja, K. K., Newton, R. C., Slater, D. M., & Giembycz, M. A. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2004 · Cited by 47
The effect of PPAR?? ligands on the proliferation and apoptosis of human melanoma cells
Placha, W., Gil, D., ska-Kie, A. D., & Laidler, P. M. (2003) · Melanoma Research · doi:10.1097/00008390-200310000-00003 · Cited by 47
Differential Regulation of Hyaluronic Acid Synthase Isoforms in Human Saphenous Vein Smooth Muscle Cells
van den Boom, M., Sarbia, M., Lipinski, K. V. W., Mann, P., Meyer-Kirchrath, J., Rauch, B. H., Grabitz, K., Levkau, B., Schrör, K., & Fischer, J. W. (2005) · Circulation Research · doi:10.1161/01.res.0000199263.67107.c0 · Cited by 46
Prostaglandins E2 signal mediated by receptor subtype EP2 promotes IgE production in vivo and contributes to asthma development
Gao, Y., Zhao, C., Wang, W., Jin, R., Li, Q., Ge, Q., Guan, Y., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep20505 · Cited by 46
Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1
Li, F., He, B., Ma, X., Yu, S., Bhave, R. R., Lentz, S. R., Tan, K., Guzmán, M. L., Zhao, C., & Xue, H. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.08.001 · Cited by 47
Significance and Therapeutic Potential of Prostaglandin E2 Receptor in Hepatic Ischemia/Reperfusion Injury in Mice *
Kuzumoto, Y., Sho, M., Ikeda, N., Hamada, K., Mizuno, T., Akashi, S., Tsurui, Y., Kashizuka, H., Nomi, T., Kubo, A., et al. (2005) · Hepatology · doi:10.1002/hep.20827 · Cited by 46
The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain
Giblin, G. M. P., Bit, R. A., Brown, S. H., Chaignot, H. M., Chowdhury, A., Chessell, I. P., Clayton, N. M., Coleman, T., Hall, A., Hammond, B., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.041 · Cited by 46
Prostaglandin E2 upregulates EGF‐stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes
Dajani, O. F., Meisdalen, K., Guren, T. K., Aasrum, M., Tveteraas, I. H., Lilleby, P., Thoresen, G. H., Sandnes, D., & Christoffersen, T. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21205 · Cited by 46
Overactive Bladder--Pharmacological Aspects
Andersson, K.-E. (2002) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655902320766006 · Cited by 46
Activation of the Thromboxane A2 Pathway in Human Prostate Cancer Correlates with Tumor Gleason Score and Pathologic Stage
Dassesse, T., de Leval, X., de Leval, L., Pirotte, B., Castronovo, V., & Waltregny, D. (2006) · European Urology · doi:10.1016/j.eururo.2006.01.036 · Cited by 46
Barrier Enhancing Signals in Pulmonary Edema
Birukov, K. G., Zebda, N., & Birukova, A. A. (2012) · Comprehensive physiology · doi:10.1002/cphy.c100066 · Cited by 46
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes
Rutkai, I., Fehér, A., Erdei, N., Henrion, D., Papp, Z., Edes, I. F., Koller, Á., Kaley, G., & Bagi, Z. A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp098 · Cited by 45
Epigenetic deregulation of the COX pathway in cancer
Cebola, I., & Peinado, M. A. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.02.005 · Cited by 45
Single-cell analysis of prostaglandin E2-induced human decidual cell in vitro differentiation: a minimal ancestral deciduogenic signal
Stadtmauer, D. J., & Wagner, G. P. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab183 · Cited by 45
Molecular Mechanisms of Amitraz Mammalian Toxicity: A Comprehensive Review of Existing Data
del Pino, J., Moyano-Cires, P. V., Anadón, M. J., Díaz, M. J. V., Lobo, M., Capo, M. A., & Frejo, M. T. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500534x · Cited by 46
The Renal Microcirculation
Navar, L. G., Arendshorst, W. J., Pallone, T. L., Inscho, E. W., Imig, J. D., & Bell, P. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00015-2 · Cited by 45
Rap1 mediates protective effects of iloprost against ventilator-induced lung injury
Birukova, A. A., Fu, P., Xing, J., & Birukov, K. G. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00462.2009 · Cited by 45
Hypoxia‐inducible factor 1α is involved in the prostaglandin metabolism of osteoarthritic cartilage through up‐regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes
Grimmer, C., Pfander, D., Swoboda, B., Aigner, T. G., Mueller, L., Hennig, F. F., & Gelse, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23136 · Cited by 45
Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells
Qi, Q., Liu, X., Zhang, Q., & Guo, S.-W. (2020) · Scientific Reports · doi:10.1038/s41598-020-57997-6 · Cited by 44
Nitroalkylation — A redox sensitive signaling pathway
Geisler, A. C., & Rudolph, T. K. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.014 · Cited by 44
Prostaglandin E2 Acts via Multiple Receptors to Regulate Plasminogen-Dependent Proteolysis in the Primate Periovulatory Follicle
Markosyan, N., & Duffy, D. M. (2008) · Endocrinology · doi:10.1210/en.2008-0591 · Cited by 44
Modulation of Stat3 Activation by the Cytosolic Phospholipase A2α and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway
Han, C. L., Demetris, A. J., Stolz, D. B., Xu, L., Lim, K., & Wu, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602201200 · Cited by 44
Retracted
An Update of Microsomal Prostaglandin E Synthase‐1 and PGE2 Receptors in Cardiovascular Health and Diseases
Yang, G., & Chen, L. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5249086 · Cited by 44
Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
Martín‐Sanz, P., Casado, M., & Boscá, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i20.3572 · Cited by 44
Dormant 5-lipoxygenase in inflammatory macrophages is triggered by exogenous arachidonic acid
Sorgi, C. A., Zarini, S., Martin, S. A., Sanchez, R. L., Scandiuzzi, R. F., Gijón, M. A., Guijas, C., Flamand, N., Murphy, R. C., & Faccioli, L. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-11496-3 · Cited by 44
EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
Sluter, M. N., Hou, R., Li, L., Yasmen, N., Yu, Y., Liu, J., & Jiang, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00816 · Cited by 44
Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF
Clarke, D. L., Belvisi, M. G., Catley, M. C., Yacoub, M. H., Newton, R. C., & Giembycz, M. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705716 · Cited by 44
Prostaglandin E2 (PGE2) Exerts Biphasic Effects on Human Tendon Stem Cells
Zhang, J., & Wang, J. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087706 · Cited by 44
Roles of Epoxyeicosatrienoic Acids in Vascular Regulation and Cardiac Preconditioning
Gauthier, K. M., Yang, W., Gross, G. J., & Campbell, W. B. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318159cbe3 · Cited by 44
Expression of the prostaglandin F receptor (FP) gene along the mouse genitourinary tract
Saito, O., Guan, Y., Qi, Z., Davis, L. S., Kömhoff, M., Sugimoto, Y., Narumiya, S., BREYER, R. M., & Breyer, M. D. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00441.2002 · Cited by 44
Self-citation
Prostaglandin E2 Inhibits Proliferation and Migration of HTR-8/SVneo Cells, a Human Trophoblast-derived Cell Line
Biondi, C., Ferretti, M. E., Pavan, B., Lunghi, L., Gravina, B., Nicoloso, M. S., Vesce, F., & Baldassarre, G. (2005) · Placenta · doi:10.1016/j.placenta.2005.07.009 · Cited by 44
Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors
Zhu, P., Genc, A., Zhang, X., Zhang, J., Bazan, N. G., & Chen, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20597 · Cited by 44
Urine concentrating defect in prostaglandin EP1-deficient mice
Kennedy, C., Xiong, H., Rahal, S. S., Vanderluit, J. L., Slack, R. S., Zhang, Y., Guan, Y., Breyer, M. D., & Hébert, R. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00183.2005 · Cited by 44
Self-citation
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome
Winn, M. P., Daskalakis, N., Spurney, R. F., & Middleton, J. P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090962 · Cited by 44
Signaling through the Prostaglandin I2Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness
Hashimoto, K., Graham, B. S., Geraci, M. W., FitzGerald, G. A., Egan, K. M., Zhou, W., Goleniewska, K., O’Neal, J. F., Morrow, J. D., Durbin, R. K., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10303-10309.2004 · Cited by 44
Prostaglandin E2/cyclooxygenase pathway in human skeletal muscle: influence of muscle fiber type and age
Liu, S. Z., Jemioło, B., Lavin, K. M., Lester, B. E., Trappe, S. W., & Trappe, T. A. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00396.2015 · Cited by 43
Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists
Hall, A., Atkinson, S. J., Brown, S. H., Chessell, I. P., Chowdhury, A., Giblin, G. M. P., Goldsmith, P., Healy, M. P., Jandu, K. S., Johnson, M. R., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.021 · Cited by 43
Shear-induced Cyclooxygenase-2 via a JNK2/c-Jun-dependent Pathway Regulates Prostaglandin Receptor Expression in Chondrocytic Cells
Abulencia, J. P., Gaspard, R. M., Healy, Z. R., Gaarde, W. A., Quackenbush, J. F., & Κωνσταντόπουλος, Κ. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301378200 · Cited by 43
PGE2 Induces IL-6 in Orbital Fibroblasts through EP2 Receptors and Increased Gene Promoter Activity: Implications to Thyroid-Associated Ophthalmopathy
Raychaudhuri, N., Douglas, R. S., & Smith, T. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015296 · Cited by 42
Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer
Hidalgo-Estévez, A. M., Stamatakis, K., Jiménez-Martínez, M., López‐Pérez, R., & Fresno, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00533 · Cited by 42
Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis
Kotlyarov, S. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179770 · Cited by 43
The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes
Pérez, S., Aspichueta, P., Ochoa, B., & Chico, Y. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.02.003 · Cited by 42
Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
Cronstein, B. N. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_1.si13 · Cited by 42
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells
Sirianni, R., Chimento, A., De Luca, A., Zolea, F., Carpino, A., Rago, V., Maggiolini, M., Andò, S., & Pezzi, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041020 · Cited by 41
Regulation of lung endothelial permeability and inflammatory responses by prostaglandin A2: role of EP4 receptor
Ohmura, T., Tian, Y., Sarich, N. A., Ke, Y., Meliton, A. Y., Shah, A. S., Andreasson, K. I., Birukov, K. G., & Birukova, A. A. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-09-0639 · Cited by 41
The Regulation of Uterine Function During Parturition: an Update and Recent Advances
Ilicic, M., Zakár, T., & Paúl, J. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00001-y · Cited by 41
Structure−Activity Relationship Studies Leading to the Identification of (2E)-3-[l-[(2,4-Dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a Potent and Selective Prostanoid EP3 Receptor Antagonist, as a Novel Antiplatelet Agent That Does Not Prolong Bleeding
Singh, J., Zeller, W. E., Zhou, N., Hategan, G., Mishra, R. K., Polozov, A., Yu, P., Onua, E., Zhang, J., Ramírez, J. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9005912 · Cited by 42
Brown adipose tissue-derived metabolites and their role in regulating metabolism
Ziqubu, K., Dludla, P. V., Mabhida, S. E., Jack, B. U., Keipert, S., Jastroch, M., & Mazibuko-Mbeje, S. E. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155709 · Cited by 45
Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
SCHERMULY, R. T., Pullamsetti, S. S., Breitenbach, S. C., Weißmann, N., Ghofrani, H. A., Grimminger, F., Nilius, S. M., Schrör, K., Meyer-Kirchrath, J., Seeger, W., et al. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-4 · Cited by 40
Prostaglandin E2 EP1 Receptor Antagonist Improves Motor Deficits and Rescues Memory Decline in R6/1 Mouse Model of Huntington's Disease
Anglada‐Huguet, M., Xifró, X., Giralt, A., Zamora‐Moratalla, A., Martín, E. D., & Alberch, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8556-x · Cited by 40
Cyclooxygenase inhibitors: drugs for cancer prevention
Shiff, S. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00087-0 · Cited by 40
Mechanisms of the prostaglandin F2α‐induced rise in [Ca2+]iin rat intrapulmonary arteries
Snetkov, V. A., Knock, G. A., Baxter, L., Thomas, G. D., Ward, J. P. T., & Aaronson, P. I. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.101394 · Cited by 40
Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling
Carboneau, L., BREYER, R. M., & GANNON, M. A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0377-7 · Cited by 41
Self-citation
Inhibition of PI3K-AKT Signaling Blocks PGE2-Induced COX-2 Expression in Lung Adenocarcinoma
Yang, J., Wang, X., Gao, Y., Fang, C., Ye, F., Huang, B. Y., & Li, L. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s263977 · Cited by 39
Regulation of endothelial cell functions by basement membrane‐ and arachidonic acid‐derived products
Pozzi, A., & Zent, R. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.7 · Cited by 39
Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2
Mastbergen, S. C., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065946 · Cited by 39
The role of PGE2 in human atherosclerotic plaque on platelet EP3 and EP4 receptor activation and platelet function in whole blood
Schober, L. J., Khandoga, A. L., Dwivedi, S., Penz, S. M., Maruyama, T., Brandl, R., & Siess, W. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0577-6 · Cited by 39
Divergent effects of prostaglandin receptor signaling on neuronal survival
Wu, L., Wang, Q., Liang, X., & Andreasson, K. I. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.055 · Cited by 39
Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy β-conglycinin
Tsuruki, T., Takahata, K., & Yoshikawa, M. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.010 · Cited by 39
Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase‐2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK‐CREB cascade
Ueno, T., & Fujimori, K. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08213.x · Cited by 38
High-resolution mapping of prostaglandin E2–dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells
Oberprieler, N. G., Lemeer, S., Kalland, M. E., Torgersen, K. M., Heck, A. J. R., & Taskén, K. (2010) · Blood · doi:10.1182/blood-2010-01-266650 · Cited by 38
Differential Regulation of Airway Smooth Muscle Cell Migration by E-Prostanoid Receptor Subtypes
Aso, H., Ito, S., Mori, A., Suganuma, N., Morioka, M., Takahara, N., Kondo, M., & Hasegawa, Y. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0158oc · Cited by 38
Selexipag for the treatment of pulmonary arterial hypertension
Skoro‐Sajer, N., & Lang, I. M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876007 · Cited by 38
14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP2 receptors in rat mesenteric artery
Yang, C., Kwan, Y. W., Au, A. L. S., Poon, C. C., Zhang, Q., Chan, S., Lee, S. M., & Leung, G. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.06.004 · Cited by 38
Cyclooxygenase type 2 is increased in obstructed rat and human ureter and contributes to pelvic pressure increase after obstruction
Nørregaard, R., Jensen, B. L., Topcu, S. O., Nielsen, S. S., Walter, S., Djurhuus, J. C., & Frøkiær, J. (2006) · Kidney International · doi:10.1038/sj.ki.5001616 · Cited by 38
Cyclic Nucleotides Promote Monocyte Differentiation Toward a DC-SIGN+ (CD209) Intermediate Cell and Impair Differentiation into Dendritic Cells
Giordano, D., Magaletti, D. M., Clark, E. A., & Beavo, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6421 · Cited by 38
Neuronal Overexpression of COX-2 Results in Dominant Production of PGE2 and Altered Fever Response
Vidensky, S., Zhang, Y., Hand, T. A., Goellner, J., Shaffer, A. F., Isakson, P. C., & Andreasson, K. I. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:1:15 · Cited by 38
Microglial EP2 as a New Target to Increase Amyloid β Phagocytosis and Decrease Amyloid β-Induced Damage to Neurons
Shie, F., Montine, K. S., BREYER, R. M., & Montine, T. J. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00509.x · Cited by 37
Self-citation
Transgenic Expression of Cyclooxygenase-2 in Hepatocytes Accelerates Endotoxin-Induced Acute Liver Failure
Han, C. L., Li, G., Lim, K., DeFrances, M. C., Gandhi, C. R., & Wu, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8027 · Cited by 37
PGE 2 downregulates LPS-induced inflammatory responses via the TLR4-NF-κB signaling pathway in bovine endometrial epithelial cells
Shen, Y., Liu, B., Mao, W., Gao, R., Feng, S., Qian, Y., Wu, J., Zhang, S., Gao, L., Fu, C., et al. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.01.004 · Cited by 37
Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor
Chang, S.-H., Liu, C. H., Wu, M.-T., & Hla, T. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.12.001 · Cited by 37
Development of second generation EP2 antagonists with high selectivity
Ganesh, T., Jiang, J., & Dingledine, R. J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.076 · Cited by 36
Protection of Hippocampal Neurogenesis from Toll-Like Receptor 4-Dependent Innate Immune Activation by Ablation of Prostaglandin E2 Receptor Subtype EP1 or EP2
Keene, C. D., Chang, R. C., Stephen, C., Nivison, M. P., Nutt, S. E., Look, A. E., BREYER, R. M., Horner, P. J., Hevner, R. F., & Montine, T. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081153 · Cited by 36
Self-citation
Activation of Thromboxane Receptor Upregulates Interleukin (IL)-1β–Induced VCAM-1 Expression Through JNK Signaling
Bayat, H., Xu, S., Pimentel, D. R., Cohen, R. A., & Jiang, B. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.150250 · Cited by 36
Immunolocalization of Low-Affinity Prostaglandin E2 Receptors, EP1 and EP2, in Adult Human Epidermis
Konger, R. L., Billings, S. D., Thompson, A. B., Morimiya, A., Ladenson, J. H., Landt, Y., Pentland, A. P., & Badve, S. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23658.x · Cited by 36
The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling
Fujino, H. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00840 · Cited by 35
Prostaglandins E2 and D2–regulators of host immunity in the model parasite Diphyllobothrium dendriticum: An immunocytochemical and biochemical study
Kutyrev, I. A., Бисерова, Н. М., Olennikov, D. N., Korneva, J. V., & Mazur, O. E. (2017) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2017.01.006 · Cited by 35
Cadmium Induces Migration of Colon Cancer Cells: Roles of Reactive Oxygen Species, P38 and Cyclooxygenase-2
Naji, S. M., Issa, K., Eid, A. A., Iratni, R., & Eid, A. H. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000106 · Cited by 35
Prostaglandin E 3 attenuates macrophage‐associated inflammation and prostate tumour growth by modulating polarization
Cui, J., Shan, K., Yang, Q., Qi, Y., Qu, H., Li, J., Wang, R., Jia, L., Chen, W., Feng, N., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16570 · Cited by 35
Effects of Basic Fibroblast Growth Factor and a Prostaglandin E2 Receptor Subtype 4 Agonist on Osteoblastogenesis and Adipogenesis in Aged Ovariectomized Rats
Aguirre, J. I., Leal, M. E., Rivera, M. F., Vanegas, S. M., Jorgensen, M., & Wronski, T. J. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070313 · Cited by 35
Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats
Matsumoto, T., Ishida, K., Nakayama, N., Taguchi, K., Kobayashi, T., & Kamata, K. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.003 · Cited by 35
Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling
Zhang, L., Jiang, L., Sun, Q., Peng, T., Lou, K., Liu, N., & Leng, J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9523-5 · Cited by 35
Food deprivation alters thermoregulatory responses to lipopolysaccharide by enhancing cryogenic inflammatory signaling via prostaglandin D2
Krall, C. M., Yao, X., Hass, M. A., Feleder, C., & Steiner, A. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00158.2010 · Cited by 35
E‐Ring 8‐isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea‐pig trachea through agonism of prostanoid receptors of the EP3‐subtype
Clarke, D. L., Giembycz, M. A., Patel, H. J., & Belvisi, M. G. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705648 · Cited by 35

Authors: Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D.
Affiliations: United States Department of Veterans Affairs (US)
ORCID: Breyer, Richard M
Breyer, Matthew D
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2001-04
Volume: 41
Issue: 1
Pages: 661-690
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.41.1.661
OpenAlex: W2129746956
Cited by: 1,011
References: 152
Citations by year: 2026: 7 · 2025: 17 · 2024: 11 · 2023: 22 · 2022: 17 · 2021: 27 · 2020: 37 · 2019: 22 · 2018: 24 · 2017: 32 · 2016: 38 · 2015: 43 · 2014: 50 · 2013: 40 · 2012: 51
FWCI: 5.37
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (GM 15431)
National Institute of Diabetes and Digestive and Kidney Diseases (DK37097, DK46205, R01DK037097, R01DK046205)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords: prostanoid receptors, G protein-coupled receptors, prostaglandins, cyclooxygenase, arachidonic acid metabolism, prostaglandin E2, prostaglandin F2alpha, prostacyclin, thromboxane A2, prostaglandin D2, receptor subtypes, ligand selectivity, splice variants, receptor desensitization, receptor phosphorylation, constitutive receptor activity, signal transduction
MeSH terms: Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Prostaglandins, Receptors, Prostaglandin, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prostanoid Receptors: Subtypes and Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks